Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Pharmaceuticals
Bristol-Myers Squibb and the Medical University of South Carolina have formed a research pact focused on fibrotic diseases such as scleroderma and renal fibrosis. MUSC says it has “unparalleled expertise” in fibrosis research. BMS’s drug pipeline includes two fibrosis treatments, and it has agreements with other organizations for potential drugs. Separately, the University of Texas System has joined a Sanofi program that funds R&D at academic institutions. Existing participants include Columbia University, Johns Hopkins University, and the University of Pennsylvania.
This article has been sent to the following recipient: